ALBRECHT DETLEF (Chief Medical Officer) sold 4.7% of their position (1K shares) of SATSUMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $22.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/3/2020ACC: 0001567619-20-016413
Officer· Chief Medical Officer
Since Sep 2019
-1K
Net shares
Net seller
$22.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1K acquired · 2K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1K
Price / share
$4.56
Trade value
$4.56K
% of position
4.9%
9/1/2020
20.21K→21.21K
Common Stock
Direct
Shares
−1K
Price / share
$22.21
Trade value
$22.21K
% of position
4.7%
9/1/2020
21.21K→20.21K
Total
Net shares
+0.00
Net value
-$17.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2020 | M · Option Exercise | +1K | $4.56 | $4.56K | 4.9% | 20.21K | 21.21K |
| Common Stock Direct | 9/1/2020 | S · Sale | −1K | $22.21 | $22.21K | 4.7% | 21.21K | 20.21K |
| Total | +0.00 | -$17.65K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1K shares
Shares
−1K
Strike price
4.56
Held after
67.47K
Exercisable
—
9/1/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1K shares | 9/1/2020 | S · Sale | −1K | 4.56 | — | 67.47K |